16 insiders have filed at CRNX since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Struthers Richard Scott | President & CEO | 1.38M | 1.329% | 13 sells $16.6M | |
| Betz Stephen F. | Chief Scientific Officer | 137.1k | 0.132% | 19 sells $5.5M | |
| Wierenga Wendall | Director | 116.1k | 0.112% | ||
| Knight Jeff E. | Chief Operating Officer | 112.0k | 0.108% | 9 sells $3.6M | |
| Wilson Marc | CFO | 111.6k | 0.107% | 7 sells $6.0M | |
| Schilke Tobin | Chief Financial Officer | 78.1k | 0.075% | 1 sells $266k | |
| Pizzuti Dana | Chief Med And Dev Officer | 66.8k | 0.064% | 20 sells $7.0M | |
| Krasner Alan Seth | Chief Medical Officer | 43.2k | 0.042% | 1 sells $210k | |
| Kalofonos Isabel | Chief Commercial Officer | 34.8k | 0.033% | 1 sells $138k | |
| Hassard James | Chief Commercial Officer | 29.3k | 0.028% | 2 sells $1.3M | |
| Fust Matthew K | Director | 22.8k | 0.022% | 5 sells $3.4M | |
| Deardorf Caren | Director | 16.3k | 0.016% | ||
| Vivaldi Coelho Rogerio | Director | 16.3k | 0.016% | 2 sells $181k | |
| Nichols Weston | Director | 16.3k | 0.016% | ||
| Bedrosian Camille L | Director | 16.3k | 0.016% | ||
| Okey Stephanie | Director | 13.3k | 0.013% | 2 sells $931k |
Full register at boothcheck.com/insiders/CRNX. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.